Last reviewed · How we verify
Propranolol Oral Product
Propranolol is a beta-blocker that works by blocking the action of certain natural chemicals in your body, such as epinephrine, on the heart and blood vessels.
Propranolol is a beta-blocker that works by blocking the action of certain natural chemicals in your body, such as epinephrine, on the heart and blood vessels. Used for Hypertension, Angina pectoris, Migraine prophylaxis.
At a glance
| Generic name | Propranolol Oral Product |
|---|---|
| Also known as | Propranolol |
| Sponsor | University Hospital, Toulouse |
| Drug class | beta-blocker |
| Target | beta-adrenergic receptors |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
This results in a decrease in heart rate and blood pressure, which can help to prevent or treat conditions such as high blood pressure, chest pain, and certain heart-related problems. Propranolol also has a calming effect on the body, which can help to reduce anxiety and prevent migraines.
Approved indications
- Hypertension
- Angina pectoris
- Migraine prophylaxis
- Essential tremor
- Atrial fibrillation for rate control
Common side effects
- Dizziness
- Fatigue
- Headache
- Nausea
- Diarrhea
Key clinical trials
- Modafinil and Cognitive Function in POTS (EARLY_PHASE1)
- A Real World Study of β2-Adrenergic Blocker Plus PD-1 Inhibitor in Non-Small Cell Lung Cancer
- Beta-blocker Administration for Cardiomyocyte Division (PHASE1)
- Propranolol in Primary Progressive Aphasia (EARLY_PHASE1)
- Propranolol Adjuvant Treatment of Focal Refractory Epilepsy (PATFRE) (EARLY_PHASE1)
- Impact of Combined Oral Contraceptive Pills on Migraine (PHASE4)
- Propranolol for Sleep Apnea Therapy (PHASE2)
- Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC. (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Propranolol Oral Product CI brief — competitive landscape report
- Propranolol Oral Product updates RSS · CI watch RSS
- University Hospital, Toulouse portfolio CI